Low response rate to a vaccination against hepatitis B in patients with end-stage liver disease;Malá účinnost vakcinace proti virové hepatitidě B u pacientů s pokročilým jaterním onemocněním

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 16, Issue 5, 2010, Pages 179-181

  Rožnovský, Luděk ^a   Orsagova I ^a   Petrousova L ^a   Tvrdik J ^b   Kabieszova L ^a   Rydlo, M ^a   Lochman, I ^c   Kloudova A ^c  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

^c Fakultní Nemocnice Ostrava ^*  (Czech Republic)

Author keywords

Anti HBs antibodies; Hepatitis B; Liver cirrhosis; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ARTICLE; END STAGE LIVER DISEASE; HEPATITIS B; HUMAN; VACCINATION; ADULT; BLOOD; FEMALE; IMMUNIZATION; IMMUNOLOGY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

ADULT; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; VACCINES, SYNTHETIC; YOUNG ADULT;

EID: 78650822541     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Carey W, Pimentel R, Westveer MK, et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol. 1990;85(12):1590-2.
2. Castells L, Esteban R. Hepatitis B vaccination in liver transplant candidates. Eur J Gastroenterol Hepatol. 2001;13(4):359-61.
3. Bonazzi PR, Bacchella T, Freitas AC, et al. Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. Braz J Infect Dis. 2008;12(4):306-9.
4. Engler SH, Sauer PW, Golling M, et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol. 2001;13(4):363-7. (Pubitemid 32319900)
5. Loinaz C, de Juanes JR, Gonzales EM, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology. 1997;44(13):235-8.
6. Pascasio JM, Aoufi S, Gash A, et al. Response to a vaccination schedule with 4 doses of 40 μg against hepatitis B virus in cirrhotic patients evaluated for liver transplantation. Transplant Proc. 2008;40(9):2943-5.
7. Rosenau J, Hooman N, Hadem J, et al. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl. 2007;13(3):367-73.
8. Marchou B, Excler JL, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedule. J Infect Dis. 1995;172(1):258-60.
9. Bernier RH, Frank JA, Nolan TF. Abscesses complicating DTP vaccination. Am J Dis Child. 1981;135(9):826-8.
10. Rosenau J, Hooman N, Rifai K, et al. Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int. 2006;19(10):828-33.
11. Urbánek P, Husa P, Galský J, et al. Standardní diagnostický a terapeutický postup chronické infekce virem hepatitidy C (HCV). Čas Lék čes. 2008;147(5):I-XII.
12. Beran J. Význam druhé generace adjuvantních prostředků v "nových" vakcínách. Klin Mikrobiol Inf Lék. 2008;14(1):5-12.